血浆血小板活化因子乙酰水解酶活性与早发性冠状动脉粥样硬化无关。
Plasma platelet-activating factor acetylhydrolase activity is not associated with premature coronary atherosclerosis.
作者信息
Shohet R V, Anwar A, Johnston J M, Cohen J C
机构信息
Department of Medicine, Center for Human Nutrition, University of Texas Southwestern Medical Center, Dallas 75235-9052, USA.
出版信息
Am J Cardiol. 1999 Jan 1;83(1):109-11, A8-9. doi: 10.1016/s0002-9149(98)00791-7.
Abstract
Platelet-activating factor acetylhydrolase activity in plasma was compared between 72 subjects with angiographically normal coronary arteries and matched controls with clinically significant obstruction. No difference was seen, and we conclude that variation in plasma platelet-activating factor acetylhydrolase activity is not a risk factor for coronary artery disease.
摘要
对72名冠状动脉造影正常的受试者和匹配的有临床显著阻塞的对照组进行了血浆中血小板活化因子乙酰水解酶活性的比较。未发现差异，我们得出结论，血浆血小板活化因子乙酰水解酶活性的变化不是冠状动脉疾病的危险因素。
Zotero 插件